CorMedix

CRMD · NASDAQ

$7.57+$0.19 (+2.57%)TodayMarket closed · Oct 20, 7:36 PM ET

Prev close $7.38

Latest news

Press releaseOct 19, 7:30 AM ETGlobe Newswire
Cormedix Announces FDA Acceptance for Priority Review of Supplemental NDA for Rezzayo® (Rezafungin) for Prophylaxis of Invasive Fungal Diseases
Press releaseOct 15, 7:30 AM ETPRNewswire
Actinium Pharmaceuticals Strengthens Leadership Team with Appointment of Matt David, M.D. as Chief Financial Officer
Press releaseAug 13, 12:27 PM ETGlobe Newswire
Today's Stocks in the News
NewsAug 13, 10:56 AM ETVandana Singh
CorMedix Stock Jumps on Strong DefenCath Sales
NewsAug 13, 9:07 AM ET
Full Transcript: Cormedix Q2 2026 Earnings Call
Press releaseAug 13, 7:30 AM ETGlobe Newswire
Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
NewsJul 16, 8:02 AM ETAvi Kapoor
Frequency Electronics Posts Weak Q4 Results, Joins AST SpaceMobile And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
NewsJul 1, 8:02 AM ETAvi Kapoor
Nike, Shutterstock And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
NewsMay 14, 1:54 PM ETVandana Singh
CorMedix Stock Jumps As DefenCath Fuels Q1 Beat, 2026 Outlook Raised
NewsMay 14, 9:09 AM ET
Cormedix Q1 2026 Earnings Call Transcript
NewsMay 14, 8:05 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsMay 14, 7:33 AM ET
Cormedix Q1 Adj. EPS $0.43 Beats $0.36 Estimate, Sales $127.427M Beat $105.017M Estimate
Press releaseMay 14, 7:30 AM ETGlobe Newswire
Cormedix Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
NewsMay 14, 7:11 AM ET
Earnings Scheduled For May 14, 2026
NewsApr 27, 1:00 PM ETVandana Singh
CorMedix Eyes $2 Billion Market With Encouraging Data From Fungal Infection Study
NewsMar 4, 1:02 PM ET
Cormedix Earnings Preview
NewsFeb 11, 8:00 AM ET
Analyst Expectations For Cormedix's Future
NewsJan 21, 5:00 PM ET
Where Cormedix Stands With Analysts
NewsJan 8, 12:33 PM ETAvi Kapoor
Dow Jumps Over 250 Points; US Initial Jobless Claims Increase
NewsJan 8, 10:02 AM ETAvi Kapoor
Nasdaq Falls Over 100 Points; Acuity Posts Upbeat Earnings
Press releaseNov 12, 4:05 PM ETPRNewswire
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
NewsNov 12, 11:49 AM ETVandana Singh
CorMedix Q3 Profit Soars As DefenCath Dialysis Demand Exceeds Expectations
NewsNov 12, 11:19 AM ETAvi Kapoor
Pharming Group Posts Upbeat Q3 Results, Joins On Holding, BigBear.ai Holdings And Other Big Stocks Moving Higher On Wednesday
Press releaseNov 12, 11:00 AM ETGlobe Newswire
Strong Earnings and Biotech Resilience Define the Midweek Momentum
Press releaseOct 22, 4:05 PM ETBusiness Wire
Halper Sadeh LLC Encourages CorMedix Inc. Shareholders to Contact the Firm to Discuss Their Rights
NewsOct 21, 6:01 PM ET
Beyond The Numbers: 4 Analysts Discuss Cormedix Stock
Press releaseOct 21, 8:30 AM ETPRNewswire
Talphera Announces the Appointment of Joe Todisco to Board of Directors
NewsOct 20, 7:36 AM ET
Market-Moving News for October 20th
NewsSep 9, 2:01 PM ET
Analyst Expectations For Cormedix's Future
Press releaseSep 8, 8:30 AM ETPRNewswire
Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market
NewsSep 2, 1:35 PM ET
10 Health Care Stocks Whale Activity In Today's Session
NewsAug 8, 4:02 PM ETAnthony Noto
Deal Dispatch: Performance Food Group And Claire's Lead A Week Of Big Auctions, Retail Woes
Press releaseAug 7, 7:10 AM ETBusiness Wire
Melinta Therapeutics Announces Strategic Acquisition by CorMedix, Underscoring Its Portfolio Value and Industry Leadership
NewsJun 26, 5:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsMay 5, 2:02 PM ET
Earnings Preview For Cormedix
NewsApr 8, 10:37 AM ETAvi Kapoor
Marvell Technology, Nvidia, Tesla, Apple And Other Big Stocks Moving Higher On Tuesday
Press releaseMar 27, 9:00 PM ETGlobe Newswire
CORMEDIX ALERT: Bragar Eagel & Squire, P.C. is Investigating CorMedix Inc. on Behalf of CorMedix Stockholders and Encourages Investors to Contact the Firm
Press releaseMar 26, 6:00 PM ETGlobe Newswire
Kirby McInerney LLP Announces Investigation Against CorMedix Inc. (CRMD) on Behalf of Investors

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Cormedix Announces FDA Acceptance for Priority Review of Supplemental NDA for Rezzayo® (Rezafungin) for Prophylaxis of Invasive Fungal Diseases

Actinium Pharmaceuticals Strengthens Leadership Team with Appointment of Matt David, M.D. as Chief Financial Officer

Today's Stocks in the News

CorMedix Stock Jumps on Strong DefenCath Sales

Full Transcript: Cormedix Q2 2026 Earnings Call

Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Frequency Electronics Posts Weak Q4 Results, Joins AST SpaceMobile And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

Nike, Shutterstock And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

CorMedix Stock Jumps As DefenCath Fuels Q1 Beat, 2026 Outlook Raised

Cormedix Q1 2026 Earnings Call Transcript

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Cormedix Q1 Adj. EPS $0.43 Beats $0.36 Estimate, Sales $127.427M Beat $105.017M Estimate

Cormedix Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Earnings Scheduled For May 14, 2026

CorMedix Eyes $2 Billion Market With Encouraging Data From Fungal Infection Study

Cormedix Earnings Preview

Analyst Expectations For Cormedix's Future

Where Cormedix Stands With Analysts

Dow Jumps Over 250 Points; US Initial Jobless Claims Increase

Nasdaq Falls Over 100 Points; Acuity Posts Upbeat Earnings

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

CorMedix Q3 Profit Soars As DefenCath Dialysis Demand Exceeds Expectations

Pharming Group Posts Upbeat Q3 Results, Joins On Holding, BigBear.ai Holdings And Other Big Stocks Moving Higher On Wednesday

Strong Earnings and Biotech Resilience Define the Midweek Momentum

Halper Sadeh LLC Encourages CorMedix Inc. Shareholders to Contact the Firm to Discuss Their Rights

Beyond The Numbers: 4 Analysts Discuss Cormedix Stock

Talphera Announces the Appointment of Joe Todisco to Board of Directors

Market-Moving News for October 20th

Analyst Expectations For Cormedix's Future

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

10 Health Care Stocks Whale Activity In Today's Session

Deal Dispatch: Performance Food Group And Claire's Lead A Week Of Big Auctions, Retail Woes

Melinta Therapeutics Announces Strategic Acquisition by CorMedix, Underscoring Its Portfolio Value and Industry Leadership

12 Health Care Stocks Moving In Thursday's After-Market Session

Earnings Preview For Cormedix

Marvell Technology, Nvidia, Tesla, Apple And Other Big Stocks Moving Higher On Tuesday

CORMEDIX ALERT: Bragar Eagel & Squire, P.C. is Investigating CorMedix Inc. on Behalf of CorMedix Stockholders and Encourages Investors to Contact the Firm

Kirby McInerney LLP Announces Investigation Against CorMedix Inc. (CRMD) on Behalf of Investors